Cesca Therapeutics (KOOL) Tops Q2 EPS by 5c

Cesca Therapeutics (NASDAQ: KOOL) reported Q2 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $3.29 million versus the consensus estimate of $4.32 million.

For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• Top Wealth Group expects net profit to double in fiscal 2026
• AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print